SciELO - Scientific Electronic Library Online

 
vol.58 issue6Glomerular diseases and living donor kidney transplantation author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Archivos Españoles de Urología (Ed. impresa)

Print version ISSN 0004-0614

Abstract

LUQUE GALVEZ, Mª Pilar; PERI CUSI, Lluis  and  CORRAL MOLINA, Juan Manuel. Living donor kidney transplantation in pediatric recipients. Arch. Esp. Urol. [online]. 2005, vol.58, n.6, pp.553-562. ISSN 0004-0614.

Currently, kidney transplantation is the treatment of choice in children with end stage renal disease, showing higher survivals than dialysis and proper weight-height, social and psychological -intellectual development. The indications for transplantation have been extended with time, so that today the indication for kidney transplantation is set for end stage renal disease with symptoms that cannot be eliminated by conservative treatment. In the pediatric age, mainly in children under two years, living donor kidney transplantation is specially indicated because it has longer survival than cadaver donor kidneys. Complications may appear: rejection, high blood pressure, infections, neoplasias, adverse events related to immunosuppressive drugs, and primary renal disease recurrences, besides surgical complications. Five-year results have improved over the last 5 decades, being mortality lower than 5%. Graft survival may reach 90% for living donor kidneys and 17% for cadaver donor. Factors related to graft survival include age (worse in receptors under 2 yr.), pretransplant dialysis, acute rejection, and race (better in caucasians).

Keywords : Kidney transplantation; Pediatric; Complications; Survival.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License